# FDA Inspection 713933 - Biomat USA, Inc - March 15, 2011

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c666f44a-deaf-4a4e-9938-fe8730e87185
Source feed: FDA_Inspections

> FDA Inspection 713933 for Biomat USA, Inc on March 15, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 713933
- Company Name: Biomat USA, Inc
- Inspection Date: 2011-03-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1099570 - 2019-07-18](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b4e186e8-8e7a-416e-b7a7-eb3f69b45e22)
- [FDA Inspection 1027218 - 2017-09-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/29b296ef-3f8a-48ab-92e0-6e9022f91ea3)
- [FDA Inspection 828903 - 2013-04-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ae6840ca-aea5-4c59-bdd6-ef940dff4fbe)

Company: https://www.keypedia.com/companies/biomat-usa-inc/c66f9985-f5c2-4ed0-b816-e8c33a49560b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d